Product
Eureka
For R&D, Eureka makes reading and utilizing patents & technical documents easy.
Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
43results about How to "Complete treatment" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Methods and compositions for treating bacterial infections and diseases associated therewith
InactiveUS20090149453A1Reduce bacterial loadReduce problemsAntibacterial agentsOrganic chemistryDiseaseMicrobiology
Owner:ACTIVBIOTICS PHARMA
Methods and compositions for treating bacterial infections and diseases associated therewith
InactiveUS20090088423A1Reduce bacterial loadReduce problemsAntibacterial agentsOrganic chemistryDiseaseMicrobiology
Owner:ACTIVBIOTICS PHARMA
Substrate treatment apparatus, and substrate treatment method
ActiveUS20160045938A1Complete treatmentAvoid mixingHollow article cleaningSemiconductor/solid-state device manufacturingControl unitChemical engineering
The inventive substrate treatment apparatus includes: a rotative treatment control unit which controls a first chemical liquid supplying unit and a second chemical liquid supplying unit to perform a first chemical liquid supplying step of supplying a first chemical liquid to a substrate rotated by a substrate holding and rotating mechanism and a second chemical liquid supplying step of supplying a second chemical liquid to the substrate rotated by the substrate holding and rotating mechanism after the first chemical liquid supplying step; and a cleaning control unit which controls the cleaning liquid supplying unit to spout the cleaning liquid from the cleaning liquid outlet port to supply the cleaning liquid to the cup inner wall and / or the base wall surface before start of the second chemical liquid supplying step after end of the first chemical liquid supplying step, and / or during and / or after the second chemical liquid supplying step.
Owner:DAINIPPON SCREEN MTG CO LTD
Catheter for removing tissue from a hollow organ
InactiveUS20080058917A1Reduce frictional resistanceEasy to observeStentsCatheterImage recordingOrgan of Corti
The invention relates to a catheter for removing tissue from a hollow organ, comprising a lumen provided in the catheter shell for supplying to the nozzle-type opening a fluid used for removal of the tissue, via which the fluid is emitted into the area of tissue adjacent to the catheter tip via the opening provided, with an integrated image recording device being provided in the area of the catheter tip of which the recording area is directed onto the area of tissue adjacent to the outlet opening. Inventively a stent is provided in the area of the catheter tip, which can be expanded to set it via a balloon located underneath it inflatable via a further lumen.
Owner:SIEMENS AG
Traditional Chinese medicine preparation for curing gout and method of preparing the same
InactiveCN101249173APrevent relapseRelieve symptomsHydroxy compound active ingredientsSkeletal disorderSide effectAdditive ingredient
The invention discloses a traditional Chinese medicine preparation for treating gout and a preparation method thereof. The traditional Chinese medicine preparation is mainly made from the raw ingredient medicines by weight parts as follows: radix rehmanniae, pawpaw, Radix Aucklandiae, angelica dahurica, Wu Chia Pee, achyranthes and radix aconiti feri are respectively 100 to 250 parts; panax notoginseng and fennel are respectively 10 to 40 parts; camphor is 25 to 75 parts; borneol is 10 to 30 parts; mush / muskone is 0.1 to 0.5 parts. Compared with the prior art, the traditional Chinese medicine preparation has specific antiphlogistic effect to non-steroid inflammation, and has the functions of clearing heat as well as removing dampness, activating blood circulation and dredging collaterals, and promoting vascular regeneration; by adopting the modern extraction technology, the invention fully extracts the active ingredients in the traditional Chinese medicine to make a external preparation which can be applied on affected parts directly; through percutaneous absorption, no liver first pass effect occurs, the traditional Chinese medicine preparation has no damage to the liver, stomach, kidney, etc., without toxic and side effects, the curative effect is good and thorough, and the relapse is avoided.
Owner:杨漓 +2
A chronic disease management system and a realization method thereof on the basis of cloud computing and mobile Internet technology
InactiveCN108269611AImprove work efficiencyReduce morbidityMedical automated diagnosisHealthcare resources and facilitiesHigh risk populationsConfiguration design
The invention discloses a chronic disease management system and a realization method thereof on the basis of cloud computing and mobile Internet technology, and belongs to the computer science field.The system comprises a chronic disease management and health service platform, an individual self-service management system, a medical institution service management system, a health center service management system and a doctor service management system, wherein the individual self-service management system, the medical institution service management system, the health center service management system and the doctor service management system are connected with the chronic disease management and health service platform. The individual self-service management system is connected with the doctorservice management system and the medical institution service management system. The doctor service management system is connected with the health center service management system. On the basis of amulti-layer loose and coupled high-scalability configuration design and a service exchange framework technique, the management system based on cloud computing and mobile Internet technology improves the work efficiency of doctors, achieves effective disease management and health management for patients suffering from chronic diseases and high-risk populations, and reduces the incidence rate, the hospitalization rate, the re-hospitalization rate and the mortality rate of chronic diseases such as heart failures.
Owner:南京明时捷信息科技有限公司
Formation method of drug coating and drug coating prepared by same
ActiveCN102988299AComplete treatmentPharmaceutical non-active ingredientsGranular deliveryDiseaseRelease time
The invention provides a formation method of a drug coating. The formation method comprises the following steps in sequence: providing at least one dried solid particle, wherein the dried solid particle comprises polymers and drug molecules; spraying a dried solid particle mixture formed by the dried solid particles on a moist surface, wherein the polymers are swelled on the moist surface, so that the physical crosslinking can be carried out between the solid particles so as to form the drug coating; or spraying the dried solid particle mixture formed by the dried solid particles on a dried surface, and then spraying atomized water drops on the surface of the dried solid particle mixture, wherein the polymers are swelled to result in physical crosslinking between the solid particles so as to form the drug coating. The drug coasting provided by the invention has the advantages that the slow release time can be controlled to reach 1 to 90 days, and preferably 3 to 30 days, so that the drug coating can be kept on the surface of a lesion part for a long time in order to come into play for a long time, and as a result, the nasal diseases such as nasosinusitis and allergic rhinitis can be treated better.
Owner:PUYI (SHANGHAI) BIOTECHNOLOGY CO LTD
Tinidazole vaginal effervescent tablet and preparation method thereof
InactiveCN102048708ASimple preparation processHigh degree of mechanizationOrganic active ingredientsAntisepticsSodium bicarbonatePolyethylene glycol
The invention relates to a tinidazole vaginal effervescent tablet and a preparation method thereof. The tinidazole vaginal effervescent tablet has the advantages of simple preparation method, good treatment effect and the like. The tinidazole vaginal effervescent tablet comprises the following components in parts by weight: 200 parts of tinidazole, 105 parts of tartaric acid, 40 parts of calcium lactate, 44 parts of lactic acid, 150 parts of starch, 6.5 parts of polyvidone K30, 20 parts of silicon dioxide, 120 parts of sodium bicarbonate, 60 parts of polyethylene glycol 4000, 4 parts of lauryl sodium sulfate and 4 parts of magnesium stearate.
Owner:赵磊
Chinese ephedra canopy powder
InactiveCN101129543ASignificant effectComplete treatmentPowder deliveryRespiratory disorderCurative effectLicorice roots
Owner:王军
Method for biogeochemical stabilization of chromate-impacted solids
InactiveUS8703078B2Reduce as muchLong-termSolid waste disposalMolybdeum compoundsAlkalinityNovel treatment method
Owner:ARCADIS U S
Ultrasonic transducer
InactiveUS20100249668A1Increase rangeImprove processing efficiencyUltrasound therapyDiagnosticsTransducerUltrasound treatment
An ultrasonic transducer has at least two sets of transducer units, with all the transducer units in each set having the same focus position and the transducer units in the different sets having different focus positions. Since the focus points of the sets of ultrasonic transducer units are distributed in a relatively large spatial range, the range of ultrasonic therapy can be increased even within the narrow and limited space of magnetic resonance imaging equipment.
Owner:SIEMENS AG
Pecan and processing method thereof
ActiveCN106722656ARemove harshnessGreat tasteFood ingredient as mouthfeel improving agentFood processing
The invention provides a pecan and a processing method thereof, and belongs to the field of food processing. The processing method comprises the following steps: picking pecans, grinding the shells of pecans, deactivating the enzymes of grinded pecans for 5 to 15 minutes at a temperature of 180 to 250 DEG C, mixing hot pecans with a material water solution for 2 to 5 minutes, taking out pecans, and cleaning the surface of the pecan shells. The processing method can effectively remove the astringent taste of pecans, and improve the taste of pecans. The shells of processed pecans can be easily removed. The obtained pecans have a fresh and crispy taste. The shell of processed pecans is light-yellowed and lustrous. Moreover, the shell is non-sticky, and can be easily removed. The hand feeling is fresh.
Owner:HANGZHOU HAOMUSI FOOD
Powder of Shenhu for clearing lung-heat
InactiveCN101130020ASignificant effectComplete treatmentPowder deliveryRespiratory disorderArecaAdemetionine
The invention relates to a Chinese medicinal powder for treating pulmonary abscess which is prepared from the following constituents: radix scrophulariae 2. 4g, stellaria root, dried orange peel, root of ballon flower, poria cocos, root bark of chinese wolf berry, ophiopogon root each 3g, seed of Job's tears 6g, ginseng, licorice root each 1. 5g, areca-nut 0. 9g and fresh ginger 1 tablet.
Owner:王军
Strategy for retroviral immunotherapy
InactiveCN101354397AComplete treatmentOrganic active ingredientsOrganic chemistryEffector cellAntigen
The invention points out generating at least two immune cell colonies at responding to retrovirus infecting mammals. In particular, the immune system of the mammals infected by the retrovirus can enhance the immune response of the retrovirus through a group of cells generally named as effector cells, however, the second immune cell colony is generated synchronously to regulate the effector cells generally named as regulation cells (or suppressor cell), so as to restrict the capability of the mammals for effectively controlling or eliminating the retrovirus infection. Therefore, the invention uses these observation results to provide a method for treating the mammals infected by the retrovirus. Moreover, the invention has found that an acute inflammatory index can be used for detecting and monitoring the response of the effector cells to the retrovirus antigen.
Owner:免疫援助有限公司
Methods and compositions for treating bacterial infections and diseases associated therewith
InactiveUS20110218195A1Reduce bacterial loadReduce problemsAntibacterial agentsOrganic chemistryDiseaseMicrobiology
Owner:ACTIVBIOTICS PHARMA
Substrate treatment apparatus, and substrate treatment method
ActiveUS9601358B2Complete treatmentAvoid mixingHollow article cleaningSemiconductor/solid-state device manufacturingCompound (substance)Control unit
Owner:DAINIPPON SCREEN MTG CO LTD
Method for Treating Radioactive Liquid Waste
PendingUS20200143952A1Excellent efficiencySafely and efficiently treatWater/sewage treatment by irradiationRadioactive contaminantsRadiation exposureNuclear power plant
The present invention relates to a technology for treating radioactive liquid waste containing a hardly degradable compound, and more specifically, to a technology for treating radioactive liquid waste containing a material such as an organic decontamination agent, an inorganic decontamination agent, liquid scintillation counter liquid waste, and the like generated at nuclear power plants, nuclear facilities, facilities at which radiation (radioactivity) is used, and the like. The method for treating radioactive liquid waste of the present invention includes adding two or more selected from the group consisting of a metal ion, an oxidizing agent, air, oxygen, or nitrous oxide, and a semiconductor to radioactive liquid waste to prepare a pre-treatment solution, and irradiating the pre-treatment solution with radiation.
Owner:KOREA ATOMIC ENERGY RES INST
System for treating malodorous gas from sludge
ActiveUS20210197115A1Ensure reliabilityAvoid breakingGas treatmentDispersed particle separationSludgeSorbent
The present application provides a system for treating malodorous gas from sludge, which includes an air compressor, a first pressure swing adsorption tower, a second pressure swing adsorption tower, a buffer tank, a decomposition tank, an exhaust gas scrubber and a vacuum device. The present invention relates to a process for treating malodorous gas from sludge treatment, which includes several steps as follow: compressing the malodorous gas by using an air compressor, and adsorbing by using a pressure swing adsorbent. The air for removing the malodorous component is configured for sludge separation and aerobic aeration in the treatment tank. When the pressure swing adsorbent reaches the design upper limit value, the intake air is stopped, decompression and desorption start, and the enriched malodorous component is sent to catalytic combustion or photocatalytic decomposition, and then the acid gas in the tail gas is neutralized with an alkaline absorbent, and finally discharged to the standard. The treatment system in the present invention has the advantages of low processing cost, reduced malodor treatment volume, complete treatment of malodorous gas, and easy disposal of three wastes.
Owner:ANHUI RESOURCE SAVING & ENVIRONMENTAL TECH CO LTD
Trenchless methods for forming curved hole channel with steel sleeve and pipeline lifting
ActiveUS20200271245A1Avoid disadvantagesClearer goal orientationPipe supportsDrilling rodsStructural engineeringPipe
Trenchless methods for forming a curved hole channel with a steel sleeve and pipeline lifting are provided, including steps of: (T1) drilling a straight hole channel, and inserting the steel sleeve into the straight hole channel; (T2) inserting a guiding pipe into the steel sleeve, and determining a bending direction of a hole channel to be formed; and (T3) inserting a flexible steel-wire pipe into the guiding pipe, and punching to form the curved hole channel. With applying the creative trenchless method for forming the curved hole channel, a specially-made grouting pipe is accurately inserted to a bottom of a subsiding pipeline section, so that a polymer material is conveniently injected to a bottom of a disease position. Though utilizing an expansion force generated by the polymer material, the subsiding pipeline section is uplifted, so as to realize trenchless repairing.
Owner:INFRASTRUCTURE RENEWAL INST OF SOUTHERN CHINA +1
Avermectin suspension and preparation method thereof
InactiveCN104208021ASolve insolubleNo residueOrganic active ingredientsClimate change adaptationDiseasePolyethylene glycol
The invention discloses an avermectin suspension and a preparation method thereof. Each 100 mL of suspension comprises the following components by weight: 1 to 3 grams of avermectin, 10 to 25 grams of absolute ethanol, 15 to 25 grams of polyethylene glycol, 0.6 to 1.3 grams of sodium carboxymethylcellulose, 0.5 to 0.7 gram of gelatin, 1 gram of tween 80, 0.5 gram of sodium benzoate, and the balance being injection water. The avermectin suspension is prepared by compounding avermectin, absolute ethanol, polyethylene glycol, sodium carboxymethylcellulose, gelatin, tween 80, and sodium benzoate, and the components mentioned above cooperate with each other to generate a synergetic effect. The provided suspension solves the problem that avermectin is hard to dissolve, can be rapidly absorbed by the gastrointestinal tracts, is completely absorbed in human body, has a high bio-utilization degree and large divergence, improves the sustained releasing and long acting effect of active components, has a rapid effect and radical curative effect on nematodosis, mite diseases, parasitic insect diseases of poultry and livestock, does not generate any drug residue, and is easy to promote and use in clinic.
Owner:ZHENGZHOU HOUYI PHARMA
Eye myopia therapeutic apparatus combining hydrogen, low frequency and magnetic therapy
PendingCN113599067APrevent myopiaSlow down presbyopiaElectrotherapyBathing devicesOphthalmologyPoor vision
The invention discloses an eye myopia therapeutic apparatus combining hydrogen, low frequency and magnetic therapy, and particularly relates to the technical field of myopia therapeutic instruments. The eye myopia therapeutic apparatus comprises a hydrogen production box, one side of the hydrogen production box is provided with a hydrogen therapy mechanism, and the hydrogen therapy mechanism is internally provided with a low frequency magnetic therapy mechanism; the hydrogen treatment mechanism comprises an electric valve pipe arranged on one side of the hydrogen production box. By arranging the hydrogen therapy mechanism and the low frequency magnetic therapy mechanism, myopia prevention, eyestrain recovery and effective improvement of the treatment effect are achieved for eyes, operation is easy, split-flow treatment and hydrogen and medicament atomization circulation are achieved, and therefore medicament and hydrogen fluidity is effectively improved, treatment is more comprehensive, the treatment effect is more comprehensive and thorough, and the blood circulation effect is improved and eyestrain is relieved. Meanwhile, treatment is carried out through magnetic therapy, the effect of treated area is further improved, and better treatment and health care effects and better practicability are achieved for poor vision and vision health care.
Owner:江苏融宝智能科技有限公司
Automated apparatus and process for the controlled shutdown and start-up for a wastewater treatment system
InactiveUS7824554B2Safely shut downSufficient volumeLiquid separation auxillary apparatusSpecific water treatment objectivesWater treatment systemSewage treatment
Owner:WATER SOLUTIONS TECH LLC
Chinese medicinal composition for treating vertigo
InactiveCN101869674BComplete treatmentNot easy to relapseHeavy metal active ingredientsSenses disorderSide effectAfter treatment
Owner:张晓玲
Traditional Chinese medicinal composition for treating dizziness symptom
InactiveCN108143924AComplete treatmentNot easy to relapseDigestive systemPlant ingredientsTreatment effectSide effect
The invention belongs to the technical field of traditional Chinese medicines, aiming at providing a traditional Chinese medicinal composition for treating the dizziness symptom through the mixing ofthe medicinal materials according to the understanding of the traditional Chinese medicine for the pathogenesis of vertigo caused by hypertension. The traditional Chinese medicinal composition is prepared from the following raw medicinal materials in parts by weight: 8-25 parts of rhizoma gastrodiae, 8-25 parts of ramulus uncariae wangii, 8-25 parts of haliotis diversicolor, 8-15 parts of radix scutellariae, 8-25 parts of radix achyranthis bidentatae, 5-15 parts of fructus gardeniae, 25-35 parts of caulis polygoni multiflori, 8-25 parts of fructus tribuli, 8-25 parts of rhizoma alismatis, 15-25 parts of radix remanniae, 8-25 parts of radix bupleuri, and 25-35 parts of kudzu vine. For the traditional Chinese medicinal composition provided by the invention, the raw materials are easily available, the treatment effect for the dizziness symptom is obvious, no relapse occurs after the dizziness symptom is completely treated, and no side effects exist after patients take the traditional Chinese medicinal composition.
Owner:范奇
Prl3 antibody
ActiveUS20200181283A1Avoid formingImprove accuracyImmunoglobulins against cell receptors/antigens/surface-determinantsAntibody ingredientsAntiendomysial antibodiesHumanized antibody
Owner:AGENCY FOR SCI TECH & RES
Diagnosis of cancer
InactiveUS20170234880A1Easy to useScreen biomarkersHydrolasesBiological material analysisOncologyCancer Cellularity
Owner:AGENCY FOR SCI TECH & RES
Pharmaceutical composition for preventing and treating high blood lipid, high blood pressure and high blood sugar, and preparation method thereof
PendingCN110141615AComplete treatmentThorough treatmentMetabolism disorderUnknown materialsSide effectWolfiporia extensa
The present invention discloses a pharmaceutical composition for preventing and treating high blood lipid, high blood pressure and high blood sugar, and a preparation method thereof. The pharmaceutical composition comprises the following raw materials in parts by mass: 150-250 parts of exocarpium citri grandis, 100-200 parts of dandelion whole plants, 100-180 parts of Xinhui dried tangerine peels,100-180 parts of poria cocos, 5-15 parts of wild chrysanthemums, 50-150 parts of coptidis rhizoma, 80-150 parts of radix codonopsis, 100-200 parts of radix scutellariae, 80-150 parts of radix salviaemiltiorrhizae, 80-150 parts of haws, 100-200 parts of cassia seeds and 1,000-2,000 parts of wild local honey. The preparation method of the pharmaceutical composition comprises the following steps: according to the ratio, the following traditional Chinese medicine raw materials of the exocarpium citri grandis, dandelion whole plant, Xinhui dried tangerine peels, poria cocos, wild chrysanthemums,coptidis rhizoma, radix codonopsis, radix scutellariae, radix salviae miltiorrhizae, haws and cassia seeds are taken, and the traditional Chinese medicine raw materials are ground into traditional Chinese medicine fine powder using a stone mill. The pharmaceutical composition for preventing and treating the high blood lipid, high blood pressure and high blood sugar has advantages of preventing andtreating high blood lipid, high blood pressure and high blood sugar, and is complete in treatment and free of side effects.
Owner:祝华
PRL3 antibody
ActiveUS11155636B2Improve accuracyConfirm resultImmunoglobulins against cell receptors/antigens/surface-determinantsAntibody ingredientsAntiendomysial antibodiesHumanized antibody
Owner:AGENCY FOR SCI TECH & RES
Pharmaceutical composition, for preventing or treating sarcopenia, containing salicornia europaea extract
ActiveCN112739361AThorough preventionComplete treatmentOrganic active ingredientsMuscular disorderBiotechnologyPharmaceutical drug
According to an embodiment of the present invention, provided are a pharmaceutical composition, for preventing or treating sarcopenia, containing a Salicornia europaea extract as an active ingredient, and a food composition, for preventing or alleviating sarcopenia, containing a Salicornia europaea extract as an active ingredient.
Owner:KOREA UNIV RES & BUSINESS FOUND
Enema liquid for treating sow constipation and preparation method thereof
PendingCN111494313AReasonable compositionGood treatment effectInorganic active ingredientsDigestive systemCelluloseTherapeutic effect
The invention discloses an enema liquid for treating sow constipation and a preparation method thereof. Every 100g of the enema liquid comprises the following components by weight: 0.1-5.0g of medicalstone powder, 2.0-6.0g of Span-65, 1.0-10.0g of Tween-81, 0.01-0.2g of benzalkonium bromide, 1.0-5.0g of liquid paraffin, 1.0-10.0g of 1, 2-propylene glycol, 1.0-8.0g of magnesium sulfate, 0.5-5.0g of sodium carboxymethyl cellulose and the balance deionized water. The enema liquid disclosed by the invention has a remarkable treatment effect on constipation of sows, is safe in clinical use and exact in effect, can quickly help to eliminate constipation after rectal drenching, and is thorough in treatment and not easy to relapse in the later period. The invention further discloses a preparationmethod, the process operability is high, raw materials and auxiliary materials are easy to purchase, production conversion is facilitated, and the market prospect is good.
Owner:李会芳
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com